In a report released today, Brett Knoblauch from Cantor Fitzgerald reiterated a Buy rating on AvePoint (AVPT – Research Report), with a price target of $8.00. The company’s shares opened today at $6.17.
Knoblauch covers the Technology sector, focusing on stocks such as Evolv Technologies Holdings, CSG Systems International, and 2U. According to TipRanks, Knoblauch has an average return of 5.8% and a 47.90% success rate on recommended stocks.
Currently, the analyst consensus on AvePoint is a Moderate Buy with an average price target of $6.60.
See today’s best-performing stocks on TipRanks >>
Based on AvePoint’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $35.51 million and a GAAP net loss of $9.2 million. In comparison, last year the company earned a revenue of $50.29 million and had a GAAP net loss of $11.67 million
Based on the recent corporate insider activity of 29 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of AVPT in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Apex Technology Acquisition Corp is a blank check company.
Read More on AVPT:
- AvePoint Fuels the Future of Secure Project Collaboration as a Microsoft Syntex Repository Services Launch Partner
- AvePoint Announces First Quarter 2023 Financial Results
- Avepoint, Inc. (AVPT) Q1 Earnings Cheat Sheet
- AvePoint Advances SaaS Management Capabilities to Help Organizations Thrive in the Digital Workplace
